These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23786194)

  • 1. Stability of three commonly compounded extemporaneous enrofloxacin suspensions for oral administration to exotic animals.
    Petritz OA; Guzman DS; Wiebe VJ; Papich MG
    J Am Vet Med Assoc; 2013 Jul; 243(1):85-90. PubMed ID: 23786194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability and uniformity of extemporaneous preparations of voriconazole in two liquid suspension vehicles at two storage temperatures.
    Nguyen KQ; Hawkins MG; Taylor IT; Wiebe VJ; Tell LA
    Am J Vet Res; 2009 Jul; 70(7):908-14. PubMed ID: 19566477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxycycline concentration over time after storage in a compounded veterinary preparation.
    Papich MG; Davidson GS; Fortier LA
    J Am Vet Med Assoc; 2013 Jun; 242(12):1674-8. PubMed ID: 23725430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of acetazolamide in suspension compounded from tablets.
    Alexander KS; Haribhakti RP; Parker GA
    Am J Hosp Pharm; 1991 Jun; 48(6):1241-4. PubMed ID: 1858804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of an extemporaneously compounded clonidine hydrochloride oral liquid.
    Levinson ML; Johnson CE
    Am J Hosp Pharm; 1992 Jan; 49(1):122-5. PubMed ID: 1570852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of procainamide hydrochloride in an extemporaneously compounded oral liquid.
    Metras JI; Swenson CF; McDermott MP
    Am J Hosp Pharm; 1992 Jul; 49(7):1720-4. PubMed ID: 1621730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and stability of diazepam suspension compounded from tablets.
    Strom JG; Kalu AU
    Am J Hosp Pharm; 1986 Jun; 43(6):1489-91. PubMed ID: 3728485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of extemporaneously prepared rufinamide oral suspensions.
    Hutchinson DJ; Liou Y; Best R; Zhao F
    Ann Pharmacother; 2010 Mar; 44(3):462-5. PubMed ID: 20150505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of extemporaneously prepared moxifloxacin oral suspensions.
    Hutchinson DJ; Johnson CE; Klein KC
    Am J Health Syst Pharm; 2009 Apr; 66(7):665-7. PubMed ID: 19299374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation.
    Pabari RM; McDermott C; Barlow J; Ramtoola Z
    Clin Ther; 2012 Nov; 34(11):2221-9. PubMed ID: 23149007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of isradipine in an extemporaneously compounded oral liquid.
    MacDonald JL; Johnson CE; Jacobson P
    Am J Hosp Pharm; 1994 Oct; 51(19):2409-11. PubMed ID: 7847406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding.
    Zhao F; Dave VS; Mar MZ; Perri JR
    Int J Pharm Compd; 2018; 22(5):433-439. PubMed ID: 30384342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of extemporaneous pediatric oral liquids compounded from tablets and drug substance: case of propranolol and theophylline.
    Muśko M; Sznitowska M
    Acta Pol Pharm; 2013; 70(1):137-45. PubMed ID: 23610969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of ciprofloxacin in an extemporaneous oral liquid dosage form.
    Johnson CE; Wong DV; Hoppe HL; Bhatt-Mehta V
    Int J Pharm Compd; 1998; 2(4):314-7. PubMed ID: 23989641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of ursodiol in an extemporaneously compounded oral liquid.
    Johnson CE; Nesbitt J
    Am J Health Syst Pharm; 1995 Aug; 52(16):1798-1800. PubMed ID: 8528836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of sotalol hydrochloride in extemporaneously prepared oral suspension formulations.
    Sidhom MB; Rivera N; Almoazen H; Taft DR; Kirschenbaum HL
    Int J Pharm Compd; 2005; 9(5):402-6. PubMed ID: 23925139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of extemporaneous enalapril maleate suspensions for pediatric use prepared from commercially available tablets.
    Sosnowska K; Winnicka K; Czajkowska-Kośnik A
    Acta Pol Pharm; 2009; 66(3):321-6. PubMed ID: 19645333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stability of quetiapine oral suspension compounded from commercially available tablets.
    Tran J; Gervase MA; Evans J; Deville R; Dong X
    PLoS One; 2021; 16(8):e0255963. PubMed ID: 34375349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of an extemporaneously compounded terbutaline sulfate oral liquid.
    Horner RK; Johnson CE
    Am J Hosp Pharm; 1991 Feb; 48(2):293-5. PubMed ID: 2003504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.